MiR-27b was decreased in both NSCLC tissues and cell lines, while its overexpression suppressed NSCLC cells proliferation and invasion, by targeting LIM kinase 1 (LIMK1) [264] and Sp1 [134]. The gene discussed is SP1; the disease is non-small cell lung carcinoma.